Cite
Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India
MLA
Kouser Sideeq Lone, et al. “Seroprevalence of SARS-CoV-2-Specific Anti-Spike IgM, IgG, and Anti-Nucleocapsid IgG Antibodies during the Second Wave of the Pandemic: A Population-Based Cross-Sectional Survey across Kashmir, India.” Frontiers in Public Health, vol. 10, Oct. 2022. EBSCOhost, https://doi.org/10.3389/fpubh.2022.967447.
APA
Kouser Sideeq Lone, S. Muhammad Salim Khan, Mariya Amin Qurieshi, Sabhiya Majid, Mohammad Iqbal Pandit, Inaamul Haq, Javid Ahmad, Ashfaq Ahmad Bhat, Khalid Bashir, Sufoora Bilquees, Anjum Bashir Fazili, Muzamil Hassan, Yasmeen Jan, Rauf-ur Rashid Kaul, Zahid Ali Khan, Beenish Mushtaq, Fouzia Nazir, Uruj Altaf Qureshi, Malik Waseem Raja, … Ishtiyaq Ahmad Sumji. (2022). Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India. Frontiers in Public Health, 10. https://doi.org/10.3389/fpubh.2022.967447
Chicago
Kouser Sideeq Lone, S. Muhammad Salim Khan, Mariya Amin Qurieshi, Sabhiya Majid, Mohammad Iqbal Pandit, Inaamul Haq, Javid Ahmad, et al. 2022. “Seroprevalence of SARS-CoV-2-Specific Anti-Spike IgM, IgG, and Anti-Nucleocapsid IgG Antibodies during the Second Wave of the Pandemic: A Population-Based Cross-Sectional Survey across Kashmir, India.” Frontiers in Public Health 10 (October). doi:10.3389/fpubh.2022.967447.